Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Aadi Bioscience
Aadi Bioscience
(AADI)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fyarro
Sirolimus
2021-11-22
2029-2040
Kidney transplantation
,
Graft rejection
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Sirolimus
hypertension
,
pulmonary hypertension
,
pulmonary arterial hypertension
,
epilepsy
,
drug resistant epilepsy
,
multiple myeloma
,
plasma cell neoplasms
,
neoplasms
,
perivascular epithelioid cell neoplasms
,
recurrence
,
colorectal neoplasms
,
sarcoma
,
non-small-cell lung carcinoma
,
neuroendocrine tumors
,
carcinoma
,
glioblastoma
,
glioma
,
syndrome
,
leigh disease
,
urinary bladder neoplasms
,
non-muscle invasive bladder neoplasms
,
neoplasm metastasis
,
lung neoplasms
,
endometrial neoplasms
,
endometrioid carcinoma
,
pancreatic neoplasms
,
stomach neoplasms
,
intestinal neoplasms
,
islet cell adenoma
,
renal cell carcinoma
,
urologic neoplasms
,
hodgkin disease
,
melanoma
,
liver neoplasms
,
squamous cell neoplasms
,
chordoma
,
ewing sarcoma
,
ovarian neoplasms
,
serous cystadenocarcinoma
,
ovarian epithelial carcinoma
Albumin
overactive urinary bladder
,
urinary incontinence
,
urinary bladder diseases
,
enuresis
,
aging
Marizomib
recurrence
,
glioblastoma
,
glioma
Calcium dobesilate
healthy volunteers/patients
,
cataract
,
inflammation
,
dry eye syndromes
,
keratoconjunctivitis sicca
,
eye diseases
,
cataract extraction
,
glaucoma
,
postoperative pain
,
vitreoretinal surgery
,
macular edema
,
retinal vein occlusion
,
macular degeneration
,
retinal detachment
,
dissociative disorders
,
refractive surgical procedures
,
conjunctivitis
,
allergic conjunctivitis
,
patient preference
,
graft vs host disease
,
keratoconus
,
pterygium
Sodium chloride
urinary bladder neoplasms
,
non-muscle invasive bladder neoplasms
Bevifimod
neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
Mrtx-849
neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
Endocrine
breast neoplasms
,
recurrence
,
triple negative breast neoplasms
Arm1
healthy volunteers/patients
,
lymphoma
,
follicular lymphoma
,
large b-cell lymphoma diffuse
,
non-hodgkin lymphoma
,
b-cell lymphoma
,
lung neoplasms
,
type 2 diabetes mellitus
,
diabetes mellitus
,
non-small-cell lung carcinoma
,
carcinoma
,
liver neoplasms
,
overweight
,
urologic neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
rheumatoid arthritis
,
arthritis
,
kidney diseases
,
kidney transplantation
,
breast neoplasms
,
alzheimer disease
,
thrombosis
,
hepatocellular carcinoma
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
exanthema
,
esophageal neoplasms
,
biliary tract neoplasms
,
adenocarcinoma
,
rectal neoplasms
,
hiv infections
,
obesity
,
small cell lung carcinoma
,
neoplasms
,
hematologic neoplasms
,
multiple myeloma
,
plasma cell neoplasms
,
colorectal neoplasms
,
glioblastoma
,
disability evaluation
,
cognition disorders
,
crohn disease
,
hepatitis
,
hepatitis a
,
hepatitis b
,
chronic hepatitis b
,
chronic hepatitis
,
hepatitis c
,
fatty liver
,
multiple sclerosis
,
sclerosis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use